GF Fund Management’s Sana Biotechnology SANA Stock Holding History

GF Fund Management’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.7K	Sell	5,637 -321	-5%	-$1.03K	﹤0.01%	483
2026 Q1	$17.2K	Buy	5,958 +724	+14%	+$2.85K	﹤0.01%	514
2025 Q4	$21.3K	Sell	5,234 -332	-6%	-$1.49K	﹤0.01%	504
2025 Q3	$19.8K	Sell	5,566 -150	-3%	-$542	﹤0.01%	488
2025 Q2	$15.6K	Hold	5,716	–	–	﹤0.01%	524
2025 Q1	$9.6K	Buy	5,716 +1,028	+22%	+$2.87K	﹤0.01%	568
2024 Q4	$7.64K	Buy	+4,688	New	+$14K	﹤0.01%	578

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

GF Fund Management's SANA Position: Q2 2026 in Review

GF Fund Management reduced its Sana Biotechnology (SANA) stake by 5.4% in Q2 2026, selling an estimated $1.03K and leaving 5,637 shares worth $19.7K. The position accounts for ﹤0.01% of the portfolio, ranked #483.

GF Fund Management first reported a position in SANA in Q4 2024 and has held it in 7 quarters since. The position peaked at $21.3K in Q4 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

GF Fund Management held 5,637 shares of Sana Biotechnology worth $19.7K as of Q2 2026.
GF Fund Management sold 321 Sana Biotechnology shares in Q2 2026, an estimated $1.03K.
Sana Biotechnology made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #483 holding.
GF Fund Management first reported a position in Sana Biotechnology in Q4 2024 and has held it in 7 quarters since.
GF Fund Management's Sana Biotechnology position peaked at $21.3K in Q4 2025.
211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.